The nation of Zimbabwe has turned down a major US healthcare agreement valued at $367m (272 million pounds) over five years because of Washington's request for confidential information.
The decision came to light after a official document from December was leaked, indicating that President Emmerson Mnangagwa felt the deal was "lopsided".
A government spokesman has since stated that the US was seeking biological samples for scientific study and commercial purposes but was not willing to share the resulting advantages from future medical innovations.
"We will now turn to the challenging and unfortunate process of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for more dialogue to reach a agreement acceptable to all parties so the nation's vital HIV programme can be sustained.
Broader Implications
This rejection comes after a similar case in neighbouring Kenya, where a high court halted a similar deal with the US after concerns were raised about the security of citizens' health data.
Since returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
The agency had administered assistance for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing direct bilateral deals to boost openness and responsibility.
According to statements, Sixteen African countries have so far signed similar agreements, constituting more than $18.3bn in committed funds.
Details of the Rejected Deal
The funds for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership could have provided immense benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment through American-funded initiatives," Tremont added.
However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".
"Zimbabwe was being asked to provide its biological resources and data for a long time, with no equivalent assurance of benefiting from any medical innovations – like new medicines or tests – that could result from that provided information," his statement read.
"In essence, our country would provide the raw materials for medical research with no certainty that the final treatments would be accessible to our people should a future disease outbreak emerge."
National Interest and International Frameworks
Mangwana further noted that the American exit from the global health body and its pursuit of bilateral health agreements were undermining frameworks previously established via the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to manage potential global health emergencies.
"This mechanism is designed to ensure that when a country contributes its samples, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to develop them."
These objections regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome ongoing discussions with our US partners on how subsequent co-operation might be structured in a way that respects the independence and interests of both nations."
Health Experts Response
A leading public health body stated it acknowledged the government's concerns, but urged that talks should continue since a large portion of the country's Aids initiatives were funded by international support.
"Where technical issues exist, such as those involving information security or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," it added.
The situation underscores the continuing tensions between accepting crucial international aid and protecting national sovereignty in an increasingly interconnected world.